Purity Specifications, Storage and Distribution for Medications Development
Closed Pre-Solicitation Posted
This opportunity was awarded. See the award notice from , or the latest special notice from .
- Solicitation number
- N01DA-22-8961
- Agency
- National Institute on Drug Abuse National Institutes of Health, Department of Health and Human Services
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
The National Institute on Drug Abuse seeks to establish a centralized repository for receiving, storing, analyzing, and distributing drug compounds from various domestic and international sources to support its research activities and those of other NIH Institutes. Interested parties must demonstrate experience administering interrelated logistics tasks, handling controlled substances, and maintaining a secure inventory of approximately 10,000 compounds in various quantities and conditions. Capability statements must address analytical testing capabilities including TLC, HPLC, MS, GC, and NMR; shipping domestically and internationally as blinded samples; and database management. Statements are due by November 15th for evaluation.
No set-aside will be used. Relevant NAICS codes include 541711 and 541712. Potential PSC codes cover research support and controlled substances handling. Interested parties must be registered under the Controlled Substances Act for Schedules I through V. Responses should include company and point of contact information, business size and socioeconomic status. The anticipated contract would establish a centralized holding site to purchase, analyze, store, and distribute compounds ranging from milligrams to kilograms to support NIH research programs.
Notice text
The major goal of this project is to provide NIDA and other NIH Institutes with a holding site which has the capability to inventory, analyze and store compounds, prepared under both non-GMP (Good Manufacturing Practices) and GMP conditions, in amounts ranging from milligram quantities to several kilograms. In accordance with the Controlled Substances Act of 1970, DEA Research Registration for Schedules II to V and potentially Schedule I controlled substances will be required.
Please see the attachment for more details.
Attachments
| File | Type | Posted |
|---|---|---|
| N01DA-22-8961_Sources Sought Notice.pdf |
Notice history
| Notice | Type | Posted |
|---|---|---|
| Purity Specifications, Storage and Distribution for Medications Development | Award Notice | |
| Purity Specifications, Storage and Distribution for Medications Development | Special Notice | |
| Purity Specifications, Storage and Distribution for Medications Development | Solicitation | |
| Purity Specifications, Storage and Distribution for Medications Development | Pre-Solicitation | |
| Purity Specifications, Storage and Distribution for Medications Development | Pre-Solicitation |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity